---
title: "Abbott Laboratories: Business Model"
description: "Abbott Laboratories revenue by business segment and geography from its fiscal 2025 Form 10-K, with each part's share, growth and profitability explained."
canonical: https://www.getswoopr.com/stocks/companies/abbott-laboratories/business-model/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Abbott Laboratories: Business Model & Revenue Engine



## Direct Answer

Abbott Laboratories reports revenue across 4 business segments in its fiscal 2025 Form 10-K. Medical Devices is the largest, with $21.4 billion of revenue (48% of the total), followed by Diagnostic Products at $8.9 billion (20%). 39% of revenue came from the United States.

## How Does Abbott Laboratories Make Money?

No single line supplies a majority of revenue: the largest, Medical Devices, is 48%, which spreads Abbott Laboratories's exposure across several demand drivers. Between fiscal 2024 and 2025, Medical Devices grew fastest (+12.6%) and Diagnostic Products slowest (-4.3%), so the revenue mix tilts toward Medical Devices while that gap lasts.

| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| Medical Devices | $21.4 billion | $19.0 billion | 48.2% | 12.6% |
| Diagnostic Products | $8.9 billion | $9.3 billion | 20.2% | -4.3% |
| Nutritional Products | $8.5 billion | $8.4 billion | 19.1% | 0.5% |
| Established Pharmaceutical Products | $5.5 billion | $5.2 billion | 12.5% | 6.6% |

![Bar chart of Abbott Laboratories revenue by segment for fiscal 2025: Medical Devices 48.2%, Diagnostic Products 20.2%, Nutritional Products 19.1%, Established Pharmaceutical Products 12.5%.](https://www.getswoopr.com/images/charts/abbott-laboratories-business-model-segment-mix.webp)
*Abbott Laboratories revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.*

## Which Abbott Laboratories Segments Earn the Most?

| Segment | FY2025 segment operating income | Segment margin |
| --- | --- | --- |
| Medical Devices | $7.2 billion | 33.7% |
| Diagnostic Products | $1.7 billion | 19.5% |
| Nutritional Products | $1.6 billion | 18.4% |
| Established Pharmaceutical Products | $1.3 billion | 23.3% |

Segment operating income is the profit measure Abbott Laboratories reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within Abbott Laboratories more safely than against another company.

## Where Does Abbott Laboratories's Revenue Come From?

Regions follow the definitions in the filing; most companies assign revenue by customer location.

| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| United States | $17.1 billion | $16.3 billion | 38.6% | 4.9% |
| All Other Countries | $16.0 billion | $14.8 billion | 36.0% | 8.1% |
| Germany | $2.8 billion | $2.5 billion | 6.2% | 8.7% |
| China | $1.9 billion | $2.1 billion | 4.3% | -9.7% |
| Switzerland | $1.9 billion | $1.7 billion | 4.2% | 7.1% |
| India | $1.9 billion | $1.8 billion | 4.2% | 3.0% |
| Japan | $1.5 billion | $1.4 billion | 3.3% | 2.4% |
| United Kingdom | $1.3 billion | $1.2 billion | 3.0% | 13.1% |

## What the Segment Figures Do Not Show

The rows above add up to 100% of Abbott Laboratories's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

## Where These Numbers Come From

Every figure on this page is a value Abbott Laboratories reported in the segment note and revenue disclosures of its Form 10-K filed February 20, 2026 (accession 0001628280-26-010185), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

## Frequently Asked Questions

### What are Abbott Laboratories's business segments?

In its fiscal 2025 Form 10-K, Abbott Laboratories reports revenue for Medical Devices, Diagnostic Products, Nutritional Products and Established Pharmaceutical Products.

### Which part of Abbott Laboratories brings in the most revenue?

Medical Devices, with $21.4 billion of revenue in fiscal 2025, or 48% of the total.

### How much of Abbott Laboratories's revenue comes from outside the United States?

61% in fiscal 2025, by the geographic breakdown Abbott Laboratories reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.

## References

- [SEC EDGAR: ABBOTT LABORATORIES Form 10-K filed February 20, 2026](https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm)
- [SEC EDGAR: ABBOTT LABORATORIES annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1800&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)
- [SEC: Financial Statement Data Sets](https://www.sec.gov/data-research/sec-markets-data/financial-statement-data-sets)

## Related Pages

- [Abbott Laboratories company dossier](https://www.getswoopr.com/stocks/companies/abbott-laboratories/)
- [Abbott Laboratories financial metrics](https://www.getswoopr.com/stocks/companies/abbott-laboratories/metrics/)
- [Abbott Laboratories financial risk indicators](https://www.getswoopr.com/stocks/companies/abbott-laboratories/risks/)
- [Abbott Laboratories peer comparison](https://www.getswoopr.com/stocks/companies/abbott-laboratories/competitors/)
- [Abbott Laboratories business model and revenue mix](https://www.getswoopr.com/stocks/companies/abbott-laboratories/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)





**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**



Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).